Equity Overview
Price & Market Data
Price: $1.88
Daily Change: +$0.02 / 1.06%
Daily Range: $1.84 - $1.88
Market Cap: $4,497,612
Daily Volume: 31,424
Performance Metrics
1 Week: 5.06%
1 Month: -20.76%
3 Months: -70.46%
6 Months: -93.44%
1 Year: -99.31%
YTD: -98.18%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in Naples, Florida.